You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NBP Exercise Disclosure
Xu Cong Claire · SEC Form 4 · Filed Sep 1, 2026
Exercise
Reported value range
Not reported
Xu Cong Claire EVP, Clinical Development
NBP
Transaction date
Aug 30, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 2 days later
NBP daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 9,382 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002114309-26-000007
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.59K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Novabridge Biosciences NBP | Sale | Aug 31, 2026 | $2.59K |
| Novabridge Biosciences NBP Current | Exercise | Aug 30, 2026 | Not reported |
| Novabridge Biosciences NBP | Exercise | Aug 30, 2026 | $0 |